AgaPharm Corp. (flash only)
Location

AgaPharm is a private biotechnology company developing a breakthrough drug that prevents or slows down the onset of blindness in diabetics, and the formation of diabetic cataracts.
It is a prescription eye drop that patients will use daily for the rest of their lives. The drug will provide a safe and cost-effective prevention and treatment option that addresses significant unmet medical needs for millions of people.
The active ingredient in our drug has already been tested in humans with few side effects. As a result, AgaPharm provides VCs seeking near-term, high-value exits the opportunity to quickly create value using a proven drug development method to shorten development times, lower costs and reduce risks.
Studies completed to date by our research partner, Canada's National Research Council, suggest the drug has considerable promise. When successful in clinical trials, it may replace surgery as the treatment of choice for combating blindness caused by diabetes.
People who visit "AgaPharm Corp. (flash only)", also find interest in followings listings . . .